Senior Specialist, Portfolio & Program Management

At Merck & Co., we are looking for an experienced Senior Specialist in Portfolio & Program Management to join our team. We are looking for a dynamic individual who is passionate about driving organizational results and has a strategic mindset.The ideal candidate will have at least 5 years of experience in program and/or portfolio management, with a proven track record of successful project delivery and strategic planning. The Senior Specialist should be an expert in developing and executing project plans, and have experience in leading teams to successful outcomes. The Senior Specialist should also have strong communication and organizational skills, be a self-starter, and have the ability to work within tight timelines.The position requires excellent business acumen, the ability to think critically and analytically, and the ability to build relationships and collaborate with key stakeholders. The Senior Specialist will have the opportunity to make a difference in our organization by leading cross-functional teams, driving efficiency and productivity, and ensuring successful project delivery. This is an exciting opportunity to join a fast-paced and innovative company.

According to JobzMall, the average salary range for a Senior Specialist, Portfolio & Program Management in Rahway, NJ 07065, USA is $90,000 - $115,000 per year. This range may vary depending on the applicant's experience, qualifications, and the specific position.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.